Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00004112
Recruitment Status : Completed
First Posted : May 25, 2004
Last Update Posted : January 17, 2018
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Julie M Vose, MD, University of Nebraska

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2000
  Study Completion Date : March 2003